✦ LIBER ✦

NICE recommends three treatments

✍ Scribed by Dvurečenskij, Anatolij; Xie, Yongjian; Yang, Aili

Book ID: 121630450
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 112 KB
Volume: 684
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-013-0619-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NICE recommends peginterferon-α

✍ Zhao, Jiakun; Wu, Ying; Wang, Yuying 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 112 KB

NICE recommends cancer tests . . .

✍ Lancsar, Emily; Swait, Joffre 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 112 KB

NICE recommends alemtuzumab for MS

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

NICE recommends canagliflozin for T2DM

✍ Coker, Kendell L.; Rosenheck, Robert 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

NICE recommends rituximab for follicular

NICE recommends rituximab for follicular lymphoma . . .

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

NICE recommends aflibercept for macular

NICE recommends aflibercept for macular oedema . . .

✍ Yu, Xingwang; Peng, Hui; Liu, Yanmin; Zhang, Yan; Shu, Yingjie; Chen, Quanjia; S 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 200 KB